Inventors with similar research interests:
Location History:
- West Orange, NJ (US) (1976 - 1990)
- Long Valley, NJ (US) (1997 - 2002)
- Hackettstwon, NJ (US) (2005)
- Mallams, NJ (US) (2005)
- Hackettstown, NJ (US) (1997 - 2014)
Company Filing History:
59 out of 1,829 
4 out of 101 
2 out of 52 
Years Active: 1976-2014
Areas of Expertise:
Title: Innovations of Alan K Mallams: A Prominent Contributor to Cyclin Dependent Kinase Research
Introduction: Alan K Mallams, based in Long Valley, NJ, has made significant strides in the field of biochemistry through his inventive contributions. With a remarkable portfolio of 61 patents, Mallams has established himself as an influential inventor, particularly in the area of cyclin dependent kinase (CDK) inhibitors.
Latest Patents: Among his latest inventions are his patents concerning substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors. This innovation provides methods for inhibiting one or more cyclin dependent kinases in patients by administering a therapeutically effective amount of certain pyrazolo[1,5-a]pyrimidine compounds. This compound is crucial in the treatment, prevention, inhibition, or amelioration of diseases associated with CDKs. Another notable patent involves N-heteroaryl pyrazolopyrimidines, which comprise a novel class of pyrazolo[1,5-a]pyrimidine compounds serving as inhibitors of cyclin dependent kinases. His methods include the preparation of these compounds and their formulations for therapeutic use.
Career Highlights: Throughout his career, Alan K Mallams has collaborated with renowned companies in the pharmaceutical sector, including Schering Corporation and Pharmacopeia Inc. His work has placed him at the forefront of innovative drug development, particularly focusing on oncology and related diseases.
Collaborations: In addition to his impressive individual achievements, Mallams has worked alongside talented colleagues such as Ronald J Doll and F George Njoroge. Together, they have contributed to advancing scientific knowledge and therapeutic methodologies, showcasing the power of collaboration in innovation.
Conclusion: Alan K Mallams exemplifies the dynamic impact that inventors can have on the medical field through innovation. His extensive patent portfolio and collaborative efforts reflect a commitment to advancing healthcare solutions, particularly through the development of cyclin dependent kinase inhibitors. His work continues to inspire upcoming inventors and researchers in the biomedical community.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.